Real-world efficacy of ramucirumab plus paclitaxel with or without nivolumab in advanced gastric and gastroesophageal junction cancers. Ann Med Res . 2026;33(3):091-098. Accessed March 30, 2026. http://www.annalsmedres.org/index.php/aomr/article/view/4905